Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

N. Buza · SciRah

Researcher profile · Semantic Scholar

N. Buza

Share profile

N. Buza — researcher profile on SciRah

h-index: 44
Works: 236
Citations: 6,053

Most-cited papers

Randomized phase II trial of carboplatin-paclitaxel compared to carboplatin-paclitaxel-trastuzumab in advanced (stage III-IV) or recurrent uterine serous carcinomas that overexpress Her2/Neu (NCT01367002): updated overall survival analysis
A. Fader, D. Roque, E. Siegel, N. Buza +20 more
2020Clinical Cancer Research249 citations Open access
Semantic Scholar
Integrated mutational landscape analysis of uterine leiomyosarcomas
Jungmin Choi, A. Manzano, W. Dong, S. Bellone +40 more
2021Proceedings of the National Academy of Sciences of the United States of America108 citations Open access
Semantic Scholar
Human Epidermal Growth Factor 2 (HER2) in Early Stage Uterine Serous Carcinoma: A Multi-Institutional Cohort Study
B. Erickson, Omar Najjar, S. Damast, A. Blakaj +11 more
2020Gynecologic Oncology75 citations Open access
Semantic Scholar
A phase II evaluation of pembrolizumab for recurrent Lynch-like versus sporadic endometrial cancers with microsatellite instability
S. Bellone, D. Roque, E. Siegel, N. Buza +29 more
2021Cancer71 citations Open access
Semantic Scholar
HER2 Testing and Reporting in Endometrial Serous Carcinoma: Practical Recommendations for HER2 Immunohistochemistry and Fluorescent In Situ Hybridization: Proceedings of the ISGyP Companion Society Session at the 2020 USCAP Annual Meeting.
N. Buza
2021International Journal of Gynecological Pathology64 citations
Semantic Scholar
A phase II evaluation of pembrolizumab in recurrent microsatellite instability-high (MSI-H) endometrial cancer patients with Lynch-like versus MLH-1 methylated characteristics (NCT02899793)
S. Bellone, D. Roque, E. R. Siegel, N. Buza +29 more
2021Annals of Oncology45 citations Open access
Semantic Scholar
Reproducibility of scoring criteria for HER2 immunohistochemistry in endometrial serous carcinoma: a multi-institutional interobserver agreement study
N. Buza, E. Euscher, X. Matías-Guiu, A. McHenry +7 more
2021Modern Pathology44 citations Open access
Semantic Scholar
Genotyping diagnosis of gestational trophoblastic disease: frontiers in precision medicine
N. Buza, P. Hui
2021Modern Pathology42 citations Open access
Semantic Scholar
The role of HER2 as a therapeutic biomarker in gynaecological malignancy: potential for use beyond uterine serous carcinoma.
Karen L. Talia, Natalie Banet, N. Buza
2022Pathology (Sydney)33 citations
Semantic Scholar
Does Specimen Type Have an Impact on HER2 Status in Endometrial Serous Carcinoma? Discordant HER2 Status of Paired Endometrial Biopsy and Hysterectomy Specimens in the Presence of Frequent Intratumoral Heterogeneity.
D. Rottmann, Hisham Assem, Nana P. Matsumoto, Serena Wong +2 more
2020International Journal of Gynecological Pathology28 citations
Semantic Scholar
Molecular and Clinicopathologic Characterization of Intravenous Leiomyomatosis
Zehra Ordulu, Hong-Yan Chai, Gang Peng, A. McDonald +8 more
2020Modern Pathology28 citations Open access
Semantic Scholar
Trastuzumab deruxtecan (DS-8201a), a HER2-Targeting Antibody–Drug Conjugate with Topoisomerase I Inhibitor Payload, Shows Antitumor Activity in Uterine and Ovarian Carcinosarcoma with HER2/neu Expression
D. Mauricio, S. Bellone, L. Mutlu, B. McNamara +17 more
2023Gynecologic Oncology26 citations Open access
Semantic Scholar
Immunohistochemistry in gynecologic carcinomas: Practical update with diagnostic and clinical considerations based on the 2020 WHO classification of tumors.
N. Buza
2021Seminars in diagnostic pathology26 citations
Semantic Scholar
Integrated mutational landscape analysis of poorly differentiated high-grade neuroendocrine carcinoma of the uterine cervix
S. Bellone, Kyungjo Jeong, M. K. Halle, C. Krakstad +34 more
2024Proceedings of the National Academy of Sciences of the United States of America25 citations Open access
Semantic Scholar
Data Set for the Reporting of Endometrial Cancer: Recommendations From the International Collaboration on Cancer Reporting (ICCR)
X. Matías-Guiu, C. Selinger, L. Anderson, N. Buza +11 more
2022International Journal of Gynecological Pathology22 citations Open access
Semantic Scholar
Characteristics of HER2 Gene Amplification by Fluorescence In Situ Hybridization in Endometrial Serous Carcinoma.
N. Buza, P. Hui
2022Archives of Pathology & Laboratory Medicine20 citations Open access
Semantic Scholar
HER2 Expression in Endometrial Cancers Diagnosed as Clear Cell Carcinoma
A. Cagaanan, B. Stelter, N. Vu, E. Rhode +7 more
2021International Journal of Gynecological Pathology20 citations
Semantic Scholar
Elimusertib (BAY1895344), a Novel ATR Inhibitor, Demonstrates in vivo Activity in ATRX Mutated Models of Uterine Leiomyosarcoma
J. Harold, S. Bellone, Diego D Manavella, L. Mutlu +18 more
2022Gynecologic Oncology19 citations Open access
Semantic Scholar
Minimal Uterine Serous Carcinoma and Endometrial Polyp: A Close Clinicopathological Relationship.
Hisham Assem, D. Rottmann, A. Finkelstein, Min-Hua Wang +4 more
2021Human Pathology17 citations
Semantic Scholar
Synergistic activity of neratinib in combination with olaparib in uterine serous carcinoma overexpressing HER2/neu.
G. Yadav, D. Roque, S. Bellone, Diego D Manavella +17 more
2022Gynecologic Oncology16 citations Open access
Semantic Scholar
DHES0815A, a novel antibody-drug conjugate targeting HER2/neu, is highly active against uterine serous carcinomas in vitro and in vivo
J. Tymon-Rosario, E. Bonazzoli, S. Bellone, A. Manzano +21 more
2021Gynecologic Oncology15 citations Open access
Semantic Scholar
Gestational Trophoblastic Disease: Contemporary Diagnostic Approach.
N. Buza
2022Surgical Pathology Clinics14 citations
Semantic Scholar
Primary Endometrial Gastric (Gastrointestinal)-type Mucinous Adenocarcinoma
Harsimar Kaur, L. H. Lin, D. Kolin, Andre Pinto +6 more
2025American Journal of Surgical Pathology13 citations
Semantic Scholar
Randomised phase II trial of weekly ixabepilone ± biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer
D. Roque, E. Siegel, N. Buza, S. Bellone +17 more
2022British Journal of Cancer13 citations Open access
Semantic Scholar
Trastuzumab deruxtecan (DS-8201a), a HER2-targeting antibody–drug conjugate, demonstrates in vitro and in vivo antitumor activity against primary and metastatic ovarian tumors overexpressing HER2
L. Mutlu, B. McNamara, S. Bellone, Diego D Manavella +17 more
2024Clinical and Experimental Metastasis12 citations
Semantic Scholar
KRAS mutation in primary ovarian serous borderline tumors correlates with tumor recurrence
A. McHenry, D. Rottmann, N. Buza, P. Hui
2023Virchows Archiv12 citations
Semantic Scholar
Correlative Assessment of p53 Immunostaining Patterns and TP53 Mutation Status by Next-Generation Sequencing in High-Grade Endometrial Carcinomas
Nana P. Matsumoto, P. Manrai, D. Rottmann, Xin-Yu Wu +3 more
2022International Journal of Gynecological Pathology12 citations
Semantic Scholar
Clinicopathologic characteristics and oncologic outcomes in adenosarcoma of gynecologic sites
Jessie Y. Li, L. Mutlu, J. Tymon-Rosario, W. Khadraoui +6 more
2021Gynecologic Oncology Reports11 citations Open access
Semantic Scholar
Reporting Results of Biomarker Testing of Specimens From Patients With Carcinoma of Gynecologic Origin: The Updated College of American Pathologists Protocol.
Gulisa Turashvili, A. Karnezis, K. Hulkower, C. Hébert +8 more
2025Archives of Pathology & Laboratory Medicine9 citations Open access
Semantic Scholar
Extrauterine epithelioid trophoblastic tumour and its somatic carcinoma mimics: short tandem repeat genotyping meets the diagnostic challenges
Na Niu, Zehra Ordulu, Z. Burak, N. Buza +1 more
2023Histopathology9 citations
Semantic Scholar
Folate receptor alpha as a successful biomarker in the treatment of low-grade serous ovarian cancer patients using preclinical and clinical models.
V. Ettorre, Beatrice Conca, Cem Demirkiran, S. Bellone +8 more
2025International Journal of Gynecological Cancer8 citations Open access
Semantic Scholar
Ovarian and uterine carcinosarcomas are sensitive in vitro and in vivo to Elimusertib, a novel ataxia-telangiectasia and Rad3-related (ATR) kinase inhibitor
Diego D Manavella, B. McNamara, J. Harold, S. Bellone +19 more
2022Gynecologic Oncology8 citations Open access
Semantic Scholar
HER2 in Gynecological Malignancies: Bridging the Gap Between Standardized Pathological Assessment and Precision Therapy.
G. Zannoni, Angela Santoro, Giuseppe Angelico, A. d'Amati +3 more
2025Critical reviews in oncology/hematology7 citations
Semantic Scholar
Targetable ERBB2/HER2 Mutations in Gynecologic Malignancies: Clinicopathological, Immunohistochemical, and Molecular Correlations
P. Manrai, A. McHenry, Tong Sun, A. Santin +5 more
2024International Journal of Gynecological Pathology7 citations
Semantic Scholar
Dataset for the Reporting of Gestational Trophoblastic Neoplasia: Recommendations From the International Collaboration on Cancer Reporting (ICCR)
P. Hui, F. Webster, R. Baergen, N. Buza +7 more
2022International Journal of Gynecological Pathology7 citations Open access
Semantic Scholar
Anastomosing Hemangioma of the Ovary With Leydig Cell Hyperplasia: A Clinicopathologic Study of 12 Cases
A. McHenry, N. Buza
2022International Journal of Gynecological Pathology7 citations
Semantic Scholar
Bilateral Signet-Ring Stromal Tumor of the Ovary: A Case Report With Next-generation Sequencing Analysis and FOXL2 Mutation Testing.
Po-Han Chen, P. Hui, N. Buza
2020International Journal of Gynecological Pathology7 citations
Semantic Scholar
Extragonadal Yolk Sac Tumor Limited to the Myometrium: Report of a Case With Potential Fertility Preservation and Molecular Analysis Suggesting Germ Cell Origin.
S. Simpson, M. Simoni, P. Hui, Hugh S. Taylor +1 more
2020International Journal of Gynecological Pathology7 citations
Semantic Scholar
The Rapidly Evolving Landscape of Human Epidermal Growth Factor Receptor 2 (HER2) Testing in Endometrial Carcinoma and Other Gynecologic Malignancies.
N. Buza
2025Archives of Pathology & Laboratory Medicine6 citations Open access
Semantic Scholar
Randomized Phase II Trial of Imiquimod with or without 9-Valent HPV Vaccine versus Observation in Patients with High-grade Pre-neoplastic Cervical Lesions (NCT02864147).
Sangini S. Sheth, J. Oh, S. Bellone, E. R. Siegel +18 more
2024Clinical Cancer Research6 citations Open access
Semantic Scholar
Randomized phase II trial of weekly ixabepilone with or without biweekly bevacizumab for platinum-resistant or refractory ovarian/fallopian tube/primary peritoneal cancer
D. Roque, E. Siegel, N. Buza, S. Bellone +17 more
2021Gynecologic Oncology6 citations
Semantic Scholar
Remarkable preclinical activity of trastuzumab-deruxtecan (T-DXd) in FISH-negative, HER2 IHC 1+ and 2+ expressing primary endometrial cancer cell lines and xenografts.
Luca Palmieri, S. Bellone, Cem Demirkiran, Tobias M. P. Hartwich +11 more
2026Gynecologic Oncology5 citations
Semantic Scholar
Gestational trophoblastic disease: STR genotyping for precision diagnosis
Krasimira A. Rozenova, N. Buza, Pei Hui
2025Expert Review of Molecular Diagnostics5 citations
Semantic Scholar
In Vivo and In Vitro Efficacy of Trastuzumab Deruxtecan in Uterine Serous Carcinoma
L. Mutlu, Diego D Manavella, S. Bellone, B. McNamara +18 more
2023Molecular Cancer Therapeutics5 citations Open access
Semantic Scholar
Corrigendum to “Elimusertib (BAY1895344), a novel ATR inhibitor, demonstrates in vivo activity in ATRX mutated models of uterine leiomyosarcoma”
J. Harold, S. Bellone, Diego D Manavell, L. Mutlu +18 more
2023Gynecologic Oncology5 citations Open access
Semantic Scholar
Integrated mutational landscape analysis of endometrial stromal sarcoma
Tobias M. P. Hartwich, Seungji Choi, Ayoung Hwang, S. Bellone +35 more
2026Proceedings of the National Academy of Sciences of the United States of America4 citations Open access
Semantic Scholar
Serous Ovarian Cancer Following Opportunistic Bilateral Salpingectomy
R. Sowamber, Alice J Mei, Paramdeep Kaur, Julianne Mcleod +44 more
2026JAMA Network Open4 citations Open access
Semantic Scholar
Preclinical activity of sacituzumab govitecan in TROP2-positive low-grade serous ovarian cancer patient-derived xenograft models.
V. Ettorre, Cem Demirkiran, S. Bellone, Na Niu +5 more
2025International Journal of Gynecological Cancer4 citations Open access
Semantic Scholar
Mixed Gestational Trophoblastic Tumors—Challenging Clinicopathological Presentations
Na Niu, N. Buza, Pei Hui
2024International Journal of Gynecological Pathology4 citations
Semantic Scholar
Diandric triploid partial mole versus digynic nonmolar triploidy: is morphological assessment sufficient for the diagnostic distinction?
Agnes Nagy, Na Niu, Tong Sun, N. Buza +1 more
2024Histopathology4 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

P. Hui×24
Invite
P. Hui — researcher profile on SciRah
S. Bellone×20
Invite
S. Bellone — researcher profile on SciRah
E. Ratner×18
Invite
E. Ratner — researcher profile on SciRah
M. Azodi×16
Invite
M. Azodi — researcher profile on SciRah

×15

Invite

G. Altwerger — researcher profile on SciRah

V. Andikyan×15

Invite

V. Andikyan — researcher profile on SciRah

Invite

A. Santin — researcher profile on SciRah

Invite

G. Huang — researcher profile on SciRah

Invite

M. Clark — researcher profile on SciRah

Invite

J. Harold — researcher profile on SciRah

Cem Demirkiran×11

Invite

Cem Demirkiran — researcher profile on SciRah

Tobias M. P. Hartwich×11

Invite

Tobias M. P. Hartwich — researcher profile on SciRah